Study tests glucagon doses for Post-Surgery low blood sugar
NCT ID NCT06986603
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how different doses of glucagon, a natural hormone that raises blood sugar, affect people who have low blood sugar after weight-loss surgery. Researchers will give 28 participants several doses of glucagon and measure their blood sugar and hormone levels. The goal is to understand how the body responds, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
-
University of Alabama
Birmingham, Alabama, 35233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will shedding pounds heal the pancreas? MRI scans seek answers
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can Weight-Loss surgery rewire the Liver's energy engine?
- Can Weight-Loss surgery alter how medications work?
- Can Fast-Acting proteins protect muscle after Weight-Loss surgery?
- Can a cheaper anesthesia combo speed up waking after bariatric surgery?